Home Healthcare Pharmaceuticals Anti-Fungal Treatment Market

Anti-Fungal Treatment Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Pyrimidines), By Therapeutic Indication (Systemic, Candidiasis, Cryptococcosis, Prophylactic Use of Antifungals, Coccidioidomycosis), By Pathogens (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton), By End-Users (Hospitals and Clinics, Dermatology Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Anti-Fungal Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Azoles
    2. Echinocandins
    3. Polyenes
    4. Allylamines
    5. Pyrimidines
  2. Anti-Fungal Treatment Market, By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
    1. Systemic
    2. Candidiasis
    3. Cryptococcosis
    4. Prophylactic Use of Antifungals
    5. Coccidioidomycosis
  3. Anti-Fungal Treatment Market, By Pathogens 2022-2034 (USD MILLION/ Units)
    1. Candida
    2. Aspergillus
    3. Cryptococcus
    4. Coccidioides Immitis
    5. Zygomycetes
    6. Trichophyton
  4. Anti-Fungal Treatment Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Dermatology Clinics
  5. Regional Anti-Fungal Treatment Market
    1. North America
      1. North America Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. North America Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. North America Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. North America Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. U.S.
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      6. Canada
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
    2. Europe
      1. Europe Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. Europe Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. Europe Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. Europe Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. U.K.
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      6. Germany
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      7. France
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      8. Spain
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      9. Italy
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      10. Russia
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      11. Nordic
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      12. Benelux
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      13. Rest of Europe
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
    3. APAC
      1. APAC Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. APAC Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. APAC Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. APAC Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. China
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      6. Korea
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      7. Japan
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      8. India
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      9. Australia
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      10. Taiwan
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      11. South East Asia
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      12. Rest of Asia-Pacific
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
    4. Middle East and Africa
      1. Middle East and Africa Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. Middle East and Africa Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. Middle East and Africa Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. Middle East and Africa Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. UAE
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      6. Turkey
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      7. Saudi Arabia
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      8. South Africa
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      9. Egypt
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      10. Nigeria
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      11. Rest of MEA
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
    5. LATAM
      1. LATAM Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. LATAM Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. LATAM Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. LATAM Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. Brazil
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      6. Mexico
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      7. Argentina
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      8. Chile
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      9. Colombia
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
      10. Rest of LATAM
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Systemic
        7. Candidiasis
        8. Cryptococcosis
        9. Prophylactic Use of Antifungals
        10. Coccidioidomycosis
        11. Candida
        12. Aspergillus
        13. Cryptococcus
        14. Coccidioides Immitis
        15. Zygomycetes
        16. Trichophyton
        17. Hospitals and Clinics
        18. Dermatology Clinics
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.